Status:
RECRUITING
Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies
Lead Sponsor:
University Hospital, Antwerp
Collaborating Sponsors:
Universiteit Antwerpen
Conditions:
Sepsis
Trauma Related Injuries
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying ...
Eligibility Criteria
Inclusion
- Admitted to the ICU of UZA
- Critically ill and predicted to be hospitalised in the ICU for \> 48 hours (i.e. mostly patients admitted for sepsis, trauma, haemorrhagic shock, neurological catastrophe … which means at risk to develop mono-or multiple organ failure)
- With arterial line in place (for blood sampling)
Exclusion
- Refusal of consent by patient or closest relative
- Postoperative patients after major surgery in whom prolonged ICU stay is not foreseen (i.e. elective cardiac surgery
Key Trial Info
Start Date :
March 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06928649
Start Date
March 13 2024
End Date
August 1 2026
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Edegem, Belgium, 2650